Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.86 USD | +2.66% | +31.07% | +40.72% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.72% | 218.67Cr | |
+73.64% | 1.24TCr | |
-18.52% | 809.14Cr | |
-0.16% | 611.76Cr | |
+14.66% | 559.29Cr | |
-14.69% | 546.52Cr | |
+39.93% | 522.64Cr | |
-16.51% | 409.81Cr | |
-27.48% | 264.53Cr | |
+1.36% | 198.95Cr |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited - Special Call